angiotensin ii has been researched along with astragaloside a in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Z; Liu, Y; Ma, C; Shi, H; Wu, D; Zhou, J | 1 |
Bian, Z; Chen, X; Gu, C; Li, S; Lu, Y; Wu, H; Xu, J; Yang, D | 1 |
Dai, RZ; Gao, F; Li, JS; Zhang, DQ; Zhang, YM | 1 |
Liu, HB; Liu, ZH; Wang, J | 1 |
Cui, L; Gao, Y; Li, SJ; Sun, Y; Wang, YP; Xie, SY; Xing, ZY; Zhang, J; Zhang, SY | 1 |
5 other study(ies) available for angiotensin ii and astragaloside a
Article | Year |
---|---|
[Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy].
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Enzyme-Linked Immunosorbent Assay; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Saponins; Triterpenes | 2009 |
Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antioxidants; Cells, Cultured; DNA, Mitochondrial; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Signal Transduction; Transcription Factors; Triterpenes | 2015 |
Astragaloside IV inhibits Angiotensin II-stimulated proliferation of rat vascular smooth muscle cells via the regulation of CDK2 activity.
Topics: Angiotensin II; Animals; Atherosclerosis; Cell Line; Cyclin-Dependent Kinase 2; G1 Phase; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; S Phase; Saponins; Triterpenes; Vascular Remodeling | 2018 |
Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Enzyme Activation; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphorylation; Pressure; Protein Serine-Threonine Kinases; Saponins; Signal Transduction; Triterpenes | 2018 |
[Effect of astragaloside Ⅳ on angiotensin Ⅱ-induced inflammatory response of vascular endothelial cells and mechanism].
Topics: Angiotensin II; Cells, Cultured; Egtazic Acid; Human Umbilical Vein Endothelial Cells; Humans; NF-kappa B; Nitric Oxide; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2022 |